Blog Categories
- Blog (all posts, listed by date of publication)
- DES Advocacy
- DES and Media
- DES Daughters
- DES Grand-Daughters
- DES Grand-Sons
- DES Mothers
- DES Research
- DES Sons
Blog Tags
Blog Posts
- 1000 Thanks to our 1000 Facebook Fans !
- 1981 DES Case: Bichler v. Eli Lilly & Co.
- 1978 DES Case: Gray v. Eli Lilly & Co. and the United States
- 1979 DES Case: Lyons v. Premo Pharmaceutical Labs, Inc.
- 1979 DES Case: Abel v. Eli Lilly & Company
- 1979 DES Case: Morrissy v. Eli Lilly & Co.
- 1980 DES Case: Ferrigno v. Eli Lilly & Co.
- 1980 DES Case: Sindell v. Abbott Laboratories
- 1981 DES Case: Diamond v. E.R. Squibb & Sons, Inc.
- 1978 DES Case: McCreery v. Eli Lilly & Co.
- 1981 DES Case: Mizell v. Eli Lilly & Co.
- 1981 DES Case: Namm v. Charles E. Frosst & Co.
- 1981 DES Case: Needham v. White Laboratories, Inc.
- 1981 DES Case: Payton v. Abbott Labs
- 1981 DES Case: Ryan v. Eli Lilly & Co.
- 1981 DES Case: Tate v. Eli Lilly & Co.
- 1982 DES Case: Bichler v. Eli Lilly & Co.
- 1982 DES Case: Dawson v. Eli Lilly & Co.
- 1982 DES Case: Helmrich v. Eli Lilly & Co.
- 1982 DES Case: Miles Laboratories, Inc v. Superior Court
- 1982 DES Case: Morton v. Abbott Laboratories
- 1982 DES Case: O’Brien v. Eli Lilly & Co.
- 1982 DES Case: Payton v. Abbott Labs
- 1982 DES Case: Pipon v. Burroughs-Wellcome Co.
- 1982 DES Case: Renfroe v. Eli Lilly & Co.
- 1983 DES Case: Fleishman v. Eli Lilly & Co.
- 1983 DES Case: Glater v. Eli Lilly & Co.
- 1983 DES Case: Mathis v. Eli Lilly & Co.
- 1983 DES Case: McElhaney v. Eli Lilly & Co.
- 1983 DES Case: McElhaney v. Eli Lilly & Co. Memorandum
- 1983 DES Case: Plummer v. Abbott Laboratories
- 1983 DES Case: Trahan v. E.R. Squibb & Sons, Inc.
- 1983 DES Case: Wetherill v. University of Chicago
- 1983 DES Case: Yustick v. Eli Lilly & Co.
- 1984 DES Case: Zafft v. Eli Lilly & Co.
- 1984 DES Case: Abel v. Eli Lilly & Co.
- 1984 DES Case: Collins v. Eli Lilly & Co.
- 1984 DES Case: Eli Lilly & Co. v. Home Ins. Co.
- 1984 DES Case: Fleishman v. Eli Lilly & Co.
- 1984 DES Case: Glater v. Eli Lilly & Co.
- 1984 DES Case: Kaufman v. Eli Lilly & Co.
- 1984 DES Case: Lord v. Parke, Davis & Company
- 1984 DES Case: Martin v. Abbott Laboratories
- 1985 DES Case: Anthony v. Abbott Laboratories
- 1985 DES Case: Bogorad v. Eli Lilly & Co.
- 1985 DES Case: Cavanaugh v. Abbott Laboratories
- 1985 DES Case: Conley v. Boyle Drug Co.
- 1985 DES Case: Eli Lilly & Co. v. Home Ins. Co.
- 1985 DES Case: Errichiello v. Eli Lilly & Co.
- 1985 DES Case: Kaufman v. Eli Lilly & Co.
- 1985 DES Case: Kensinger v. Abbott Laboratories
- 1985 DES Case: Magallanes v. Superior Court
- 1985 DES Case: McCormack v. Abbott Laboratories
- 1985 DES Case: McMahon v. Eli Lilly & Co.
- 1985 DES Case: Murphy v. E.R. Squibb & Sons, Inc.
- 1985 DES Case: Pine v. Eli Lilly & Co.
- 1985 DES Case: Schaeffer v. Eli Lilly & Co.
- 1986 DES Case: Burnside v. Abbott Laboratories
- 1986 DES Case: Hadden v. Eli Lilly & Co.
- 1986 DES Case: Mulcahy v. Eli Lilly & Co.
- 1987 DES Case: George v. Parke-Davis
- 1987 DES Case: Greene v. Abbott Labs
- 1987 DES Case: Rubel v. Eli Lilly & Co.
- 1988 DES Case: Tigue v. E.R. Squibb & Sons, Inc.
- 1987 DES Case: Tigue v. Squibb & Sons
- 1988 DES Case: Brown v. Eli Lilly & Co.
- 1988 DES Case: Brown v. Superior Court
- 1988 DES Case: Castrignano v. E.R. Squibb & Sons, Inc.
- 1988 DES Case: Enright v. Eli Lilly & Co.
- 1988 DES Case: Johnson v. Eli Lilly & Co.
- 1988 DES Case: Jolly v. Eli Lilly & Co.
- 1988 DES Case: Kortenhaus v. Eli Lilly & Co.
- 1988 DES Case: Maloney v. American Pharmaceutical Co.
- 1988 DES Case: Needham v. White Laboratories, Inc. Rehearing
- 1988 DES Case: Shields v. Eli Lilly & Co.
- 1988 DES Case: Shields v. Eli Lilly & Co. Memorandum
- 1988 DES Case: Shirkey v. Eli Lilly & Co.
- 1988 DES Case: Smith v. Eli Lilly & Co.
- 1988 DES Case: Tidler v. Eli Lilly & Co.
- 1989 DES Case: Besser v. Squibb & Sons
- 1989 DES Case: Brownfield v. Daniel Freeman Memorial Hospital
- 1989 DES Case: Clark v. Eli Lilly & Co.
- 1989 DES Case: Hymowitz v. Eli Lilly & Co.
- 1989 DES Case: Murphy v. Eli Lilly & Co.
- 1989 DES Case: Phillips v. Cooper Laboratories
- 1989 DES Case: Wood v. Eli Lilly & Co.
- 1990 DES Case: Allen v. Abbott Labs.
- 1990 DES Case: Anderson v. Eli Lilly & Co.
- 1990 DES Case: Bowen v. Eli Lilly & Co.
- 1990 DES Case: Castrignano v. E.R. Squibb & Sons, Inc.
- 1990 DES Case: Clark v. Abbott Labs.
- 1990 DES Case: Enright v. Eli Lilly & Co.
- 1990 DES Case: Korren v. Eli Lilly & Co.
- 1990 DES Case: Krist v. Eli Lilly & Co.
- 1990 DES Case: Metauro v. Abbott Labs
- 1990 DES Case: Shields v. Eli Lilly & Co.
- 1990 DES Case: Singer v. Eli Lilly & Co.
- 1990 DES Case: Smith v. Eli Lilly & Co.
- 1990 DES Case: Sorrells v. Eli Lilly & Company
- 1991 DES Case: Anderson v. Eli Lilly & Co.
- 1991 DES Case: Conley v. Boyle Drug Co.
- 1991 DES Case: Enright v. Eli Lilly & Co.
- 1992 DES Case: Bowe v. Abbott Laboratories, Inc.
- 1992 DES Case: Grover v. Eli Lilly & Co.
- 1992 DES Case: Hibbs v. Abbott Laboratories
- 1992 DES Case: Moll v. Abbott Lab.
- 1992 DES Case: Silveri v. Eli Lilly & Co.
- 1993 DES Case: Ashley v. Boehringer Ingelheim Pharmaceuticals
- 1993 DES Case: Bilello v. Abbott Laboratories
- 1993 DES Case: Burgess v. Eli Lilly & Co.
- 1993 DES Case: Burgess v. Eli Lilly & Co.
- 1993 DES Case: Hartnett v. Schering Corp.
- 1993 DES Case: Moll v. Abbott Laboratories
- 1993 DES Case: Wind v. Eli Lilly & Co.
- 1994 DES Case: Millar-Mintz v. Abbott Laboratories
- 1994 DES Case: Wind v. Eli Lilly & Co.
- 1994 DES Case: Wood v. Eli Lilly & Co.
- 1995 DES Case: Boaz v. Boyle & Co.
- 1995 DES Case: Braune v. Abbott Laboratories
- 1995 DES Case: Fraser v. Eli Lilly & Co.
- 1995 DES Case: Jellow v. Abbott Laboratories
- 1996 DES Case: Mevis v. Eli Lilly & Co. et al.
- 1996 DES Case: Wetherill v. Eli Lilly & Co.
- 1997 DES Case: Kurczi v. Eli Lilly & Co.
- 1997 DES Case: Kush v. Abbott Laboratories
- 1997 DES Case: Wetherill v. Eli Lilly & Co.
- 1997 DES Case: Wood v. Eli Lilly & Co.
- 1997 DES Case: Wood v. Eli Lilly & Co.
- 1997 DES Case: Wood v. Eli Lilly & Company
- 1998 DES Case: Sutowski v. Eli Lilly & Co.
- 2001 DES Case: Armata v. Abbott Laboratories
- 2002 DES Case: Armata v. Abbott Labs
- 2003 DES Case: Albers v. Eli Lilly & Co.
- 2004 DES Case: Albers v. Eli Lilly & Company
- 2005 DES Case: Baughn v. Eli Lilly & Co.
- 2005 DES Case: Bortell v. Eli Lilly & Co.
- 2005 DES Case: Dunseth v. Eli Lilly & Co.
- 2005 DES Case: Gassmann v. Eli Lilly & Co.
- 2005 DES Case: Reeves v. Eli Lilly & Co.
- 2006 DES Case: Clayton v. Eli Lilly & Co.
- 2007 DES Case: Galvin v. Eli Lilly & Co.
- 2007 DES Case: Kelley v. Eli Lilly & Co.
- 2012 DES Case: Mazzei v. Abbott Laboratories & Co.
- 2013 DES Breast Cancer Trial – Arline MacCormack Interview
- 2013 DES Breast Cancer Trial – Jackie White Interview
- 2013 DES Breast Cancer Trial – Ann and Caitlin McCarthy Interviews
- 2013 DES Breast Cancer Trial – Settlement reached for the Melnick sisters
- A genetic mechanism for DES-induced carcinogenesis ?
- A genomic point-of-view on environmental factors influencing the human brain methylome
- A psycho-endocrinological overview of transsexualism
- A Sex Difference in the Human Brain and its Relation to Transsexuality
- DES-induced abdominal cryptorchidism
- Aberrant epididymal tissue: a significant clinical entity
- Abnormal gonadotropin secretory responses to LRH in transsexual women after diethylstilbestrol priming
- About the genotoxicity and the DNA-damaging activity of DES
- L’action de groupe en matière de produits de santé
- L’action de groupe en justice, pour les victimes du DES, en 2017
- Experimental studies on the activity and toxicity of stilbestrol
- ADAM7 gene expression might be a biological marker of fetal or neonatal DES exposure
- Adapting Due Process to Match Your Tort
- DES possible adverse affects on the postnatal human immune system
- Adverse health outcomes in women exposed in utero to diethylstilbestrol
- Pregnancy outcomes in women exposed in utero to diethylstilbestrol
- Adverse outcomes of pregnancy in women exposed to diethylstilbestrol in utero
- New AFSSAPS DES survey and update
- Against Genetic Exceptionalism
- Age/sex dependent and non-monotonous dose-response effect of DES on the immune functions
- DES Diethylstilbestrol reviews
- Alteration in DES-induced mutagenicity and cell transformation by exogenous metabolic activation
- Alterations of antibody response after neonatal exposure to DES
- DES induce alterations in the germ line and in somatic cells
- Alterations of Immune Function in the DES Exposed
- Alterations in estrogen levels during development affects the skeleton: use of an animal model
- Alterations of maternal estrogen levels during gestation affect the skeleton of female offspring
- Altered expression of genes reported to persist in DES-lineage females
- Neonatal DES exposure and altered gene expression patterns
- Altered immune response in adult women exposed in utero to DES
- Altered protein response, atypical gene expression following DES exposure early in development
- Altered PTEN Expression as a Diagnostic Marker for the Earliest Endometrial Precancers
- Alternative Liability and Deprivation of Remedy
- AMH and AMHRII mRNAs expression levels
- An Endocrine-Disruption Theory of Schizophrenia
- An Examination of the Legal and Ethical Public Policy Consideration Underlying DES Market Share Liability
- “An unconscionable delay”: warnings about DES ignored
- Androgen and the development of human sex-typical behavior
- Animal model for age- and sex-related genotoxicity of DES
- Animal models of prenatal exposure to diethylstilboestrol
- Correlations between Apolipoprotein D (APOD) and DES
- Apoptosis associated genes regulated in response to DES
- Induction of apoptosis in murine fetal thymocytes following perinatal exposure to DES
- Appellate Division Recognizes Preconception Tort Liability in Favor of DES Granddaughter
- Applying Concerted Action to the DES Cases
- DES neonatal exposure effects on AQP9 expressions in the epididymal efferent ducts, liver
- DES-induced change in AR immunoexpression
- Are EDCs Blurring Issues of Gender?
- Are implantation and pregnancy outcome impaired in DES-exposed women after IVF and embryo transfer?
- Association between fetal DES-exposure and psychiatric disorders in adolescence/adulthood
- Association of Increased Prenatal Estrogen with Risk Factors for Autism
- Interview with DES Attorney Michael London
- Atypical Gender Development – A Review
- Atypical gene expression after DES-exposure early in development
- Autism and Down’s Syndrome Risk in Diethylstilbestrol-exposed Offspring
- L’autonomie relative du préjudice d’anxiété en matière de DES
- Molecular mechanisms through which DES triggers thymic atrophy, specifically autophagy
- Bacterial and parasite susceptibility following DES exposure
- Basic Statistics and Findings on DES Sons
- Beneficial effect of hysteroscopic metroplasty on the reproductive outcome in a T-shaped uterus
- 1977 DES Case: Bichler v. Willing
- Birth defects and oestrogens and progesterones in pregnancy
- Birth Defects in DES Grandsons
- Birth Defects in the Sons and Daughters of Women who were Exposed in utero to Diethylstilbestrol (DES)
- Birth weight and breast cancer risk
- DES In Utero Exposure and Blood DNA Methylation
- ERα’s role in DES-induced breast cancer cell proliferation
- Breast cancer epidemiology : summary and future directions
- DES Research Heats Up Again After Breast Cancer Finding
- Breast cancer following DES exposure in utero
- Breast cancer following diethylstilbestrol exposure in utero
- Breast Cancer in DES Daughters
- Breast cancer in DES-exposed mothers, 1980
- Oestrogen treatment and breast cancer link
- Does breast cancer originate in utero?
- Breast cancer predisposition due to prenatal DES exposure
- DES and breast cancer risk
- Maternal factors and breast cancer risk among young women
- Increased breast cancer risk in DES daughters, granddaughters and great granddaughters
- Breast cancer risk for women exposed in utero and their offspring
- Breast Cancer Risk in DES Mothers
- Breast cancer risk in DES offspring
- Breast cancer screening in DES Daughters
- DES exposure induces permanent changes in the c-fos expression pattern
- DES amplification of the c-myc gene
- California Expands Tort Liability under the Novel Market Share Theory
- Can anybody really predict a child’s final mature height?
- Cancer du Sein chez les Filles DES
- Increased Risk of Cancer in DES Grandsons and Granddaughters
- Cancer Can Be Inherited via Epigenetics
- Diethylstilbestrol and the Risk of Cancer, 1979
- Cancer Risk in DES Daughters
- Cardiovascular birth defects and antenatal exposure to female sex hormones
- Neonatal malformations and hormone therapy during pregnancy
- Causation and Risk in the Law of Torts
- DES causative role in breast cancer through inducing aneuploidy
- Cell cycle kinetics altered in the developing uterus following neonatal exposure to DES
- Cellular and molecular effects of developmental exposure to diethylstilbestrol
- Cerebral lateralization : biological mechanisms, associations, and pathology
- Cerebral lateralization is delayed in children who later develop schizophrenia
- Degré de certitude de l’imputabilité des troubles de la fertilité ou de la gestation au DES
- Cervical cerclage in early pregnancy
- Possibilité de changer d’avocat en cours de dossier, de procédure
- Changes in Testicular DNA Produced in BALB/c Mice by Diethylstilbestrol
- Developmental programming : DES exposure induces changes in the expression of several uterine genes
- Chemical castration with DES as an alternative to prison
- Best Wishes for a Chemical-Free Holiday Season!
- Chemically-Induced Alterations in Sexual and Functional Development
- Childhood influences on adult disease
- Childhood play behavior and adult gender-role behavior in DES-exposed women
- Children’s Search for Gender Cues
- Aneuploidy Induction and Cell Transformation by DES
- Civil courts as the preferred choice
- DES clinical experiment (prevention of late pregnancy complications), 1949
- Clinical findings and legal resolution in sexual assault
- Clinical implications of the organizational and activational effects of hormones
- The clinical management of repeated early pregnancy wastage
- Clinical Studies on Stilbestrol
- Clinical Use of DES for Suppression of Sexual Behaviour
- Cognitive Ability and Cerebral Lateralisation in Transsexuals
- Cognitive theories of early gender development
- A collective legal battle
- Pourquoi le combat judiciaire du distilbène est très particulier
- Comparison of multiple assays for kinetic detection of apoptosis in thymocytes exposed to DES
- Comparison of Pregnancy Experience in DES-Daughters and unexposed Women
- Compensation for Diethylstilbestrol Injury, an Opinion
- Complications of pregnancy in mice exposed prenatally to DES
- Concert of Action by Substantial Assistance
- Formal proofs have been made on the direct role DES
- A consensus against the laboratories
- Conséquences pour les mères, filles et fils DES (2016)
- Conséquences pour les petits-enfants DES
- Continued follow-up of pregnancy outcomes in diethylstilbestrol-exposed offspring
- Contraception – the morning after
- Contraception in adolescence
- DES contraceptive effects
- Procès DES : Cour d’Appel de Versailles, n° 14/01313, 14 avril 2016
- Procès DES : Cour de cassation, Chambre civile 1, Pourvoi 14-23909, 14 avril 2016
- Procès DES : Cour de cassation, Chambre civile 1, Pourvois 16-19047 et 16-23033, 22 juin 2017
- Procès DES : Cour de cassation, Chambre civile 2, Pourvoi 14-19481, 2 juillet 2015
- Procès DES : Cour de cassation, Chambre civile 2, Pourvoi 16-19185, 8 juin 2017
- Cryptorchidism and endocrine disrupting chemicals
- Update on cryptorchidism : endocrine, environmental and therapeutic aspects
- DES Sons and Cryptorchidism, Testicular Hypoplasia, Semen Abnormalities
- Update on cryptorchidism: endocrine, environmental and therapeutic aspects
- Male reproductive disorders in humans and prenatal indicators of estrogen exposure
- La date de consolidation : plus complexe pour les maladies
- Daughters at Risk : a Personal DES History
- DES Daughters and Breast Cancer Risk
- Breast Tissue of DES Daughters
- DES Daughters’ Cancer Risk
- Do environmental estrogens contribute to the decline in male reproductive health ?
- DES linked to functionally defective natural killer cell population
- Defendant Indeterminacy: New Wine into Old Skins
- Estrogen-induced expression of mouse lactate dehydrogenase-A gene
- Delayed adverse effects of contraceptives
- Depression and anxiety doubled in the DES-exposed offspring
- Depression and diethylstilbestrol exposure in women
- DES Activist outside USA
- DES Adverts from Farming and Pharma Industries
- DES affects the development of early life stage and targets gene expression
- DES can alter sex-specific genetic pathways governing early differentiation and cell proliferation
- DES alters positive and negative selection of T cells in the thymus and modulates T-cell repertoire in the periphery
- Diethylstilbestrol and a Proposed Theory of Enterprise Liability
- DES and Emotional Distress: Payton v. Abbott Labs
- DES and Endocrine Disruptor Chemicals Research Guides
- DES and The Identification Problem
- DES and the risk of psychiatric disorders
- Wanted: DES Aware Doctors
- DES Awareness Week
- DES Books Library
- 2013 DES Breast Cancer Trial – Jury Selected
- 2011 Historic DES Breast Cancer Court Cases
- DES and Breast Cancer Risks
- DES Cancer Link 40th Anniversary
- DES Cases and Identification of Parties
- Diethylstilbestrol Contraindicated in Pregnancy
- My DES Daughter Journey – Introduction
- My DES Daughter Journey – Doctors
- My DES Daughter Journey – Interview with June Stoyer
- DES Daughter: The Joyce Bichler Story
- DES Daughters
- DES Daughters and Breast Cancer
- DES Daughters and Reproduction: 1986 update
- DES Daughters’ Breast Cancer Management
- DES daughters in France: experts’ points of view on the various genital, uterine and obstetric pathologies, and in utero DES exposure
- DES effect of on the rate of osseous repair, bone integrity, and plasma calcium
- Diethylstilbestrol effect on fetal development, gestation duration, number of offspring
- Abnormal semen analyses in the DES-exposed males
- DES, Guilt, Fear, and other Emotions
- DES enhance autoantibody production by B1 cells
- DES exposure linked to altered expression levels of DNA methyltransferases and DNA methylation
- DES Prenatal Exposure and Genomic Imprinting
- Diethylstilbestrol exposure and masculinization in females
- DES exposure effect on gonadal development
- DES exposure effect on immunohematology and bone growth
- Diethylstilbestrol exposure effects, during gestation, on maternal and offspring behavior
- DES exposure: implications for childbearing
- DES exposure : implications for health care providers
- DES exposure in utero associated with cryptorchidism, testicular hypoplasia and semen abnormalities
- DES exposure linked to disordered gene expression and eventual neoplastic transformation
- DES exposure linked to rudimentary or malformed ovaries
- DES exposure suppresses ovalbumin-gene expression and decreases DNA content
- DES exposure associated with xenobiotic-induced immune system perturbations
- DES gender-specific effects on weight gain, bone development
- DES Genetic Activity in Saccharomyces Cerevisiae
- Diethylstilbestrol Given to See if it could Stop Girls from Growing Unsociably Tall
- DES Grandsons Hypospadias ; True Transgenerational Effect ?
- New Online Global DES Health History Survey
- DES immunotoxic effects : selective diminution of T lymphocyte progenitors in fetal liver
- Diethylstilbestrol in the prevention and treatment of complications of pregnancy
- Do breast tissue of women exposed in utero to DES exhibit genetic abnormalities ?
- DES induce permanent, irreversible disturbances in lymphocyte populations and functions
- DES-induced chromosomal trisomy
- DES-induced genes and DES-repressed genes (DNA microarray analysis)
- Characterization of DES-induced hypospadias in female mice
- DES induction of hypospadias due to impaired growth and tissue fusion events during development
- DES inhibition of the expression of bone matrix protein genes in periosteal cells
- DES inhibits activation of TP63 and induces adenosis through ERα within vaginal or cervical epithelial cells
- Thousands of people believe DES is the reason they are transgender
- Diethylstilbestrol markedly influence the immune system
- DES-mediated fetal testis dysgenesis and cryptorchidism
- DES-Mother and DES-Daughter Relationship
- DES Mothers and Breast Cancer
- DES mothers may manifest increased vulnerability to subsequent stresses in their lives
- DES National Public Education Campaigns
- DES’ other Daughters
- Placental exposure to DES may cause temporal changes in gene expression
- DES Prenatal Exposure Effects on Human Development
- DES prenatal exposure : transient altered expression of ER alpha and expression of the p21 gene
- French study reveals more damaging DES side effects
- DES regulates trophoblast stem cell differentiation as a ligand of orphan nuclear receptor ERR beta
- DES-Related Endocrine Disturbances in Women
- Diethylstilbestrol revisited : a review of the long-term health effects
- DES Sons
- DES Sons and the Significance of Gender Identity
- DES Sons and Gender Dysphoria, Transsexualism, Disorders of Sexual Differentiation
- DES Sons Numbers and Health Concerns
- DES Sons Studies
- DES Sons Urogenital Abnormalities, 2009
- New Study Suggests Lifetime Risk of Adverse Health Outcomes for DES Daughters
- DES (Diethylstilbestrol) Symposium
- DiEthylStilbestrol and the temptation to tinker with a child’s height
- DES tested on pregnant women without consent: ethical violations
- DES: The Bitter Pill
- DES: The Complete Story
- DES was, at one time, the mainstay of transgender hormone treatment
- DES Use for Postcoital Contraception
- Diethylstilbestrol DES use to prevent miscarriages and other adverse pregnancy outcomes
- DES Videos in English language
- Developmental changes in testicular sensitivity to DES throughout fetal life
- Developmental effects of endocrine-disrupting chemicals in human
- Developmental effects of diethylstilbestrol and other EDCs on obesity
- Developmental exposure to diethylstilbestrol at low doses alters femur length and tensile strength
- Developmental exposure to estrogenic compounds and obesity
- Developmental exposure to estrogens induces persistent changes in skeletal tissue
- Developmental Immunotoxicity, Perinatal Programming, and Noncommunicable Diseases
- Developmental origins of health and disease
- DES Developmental Programming and Fetal Origins of Adult Disease
- Variety of developmental, reproductive and transgenerational effects of DES
- Developmental reprogramming caused by early-life exposure to DES
- Developmental reprogramming of cancer susceptibility
- Developmental toxicity but no immunotoxicity after prenatal exposure to DES
- 1979 DES Case: Diamond v. E.R. Squibb & Sons, Inc.
- Did the DES drug make some children transgender ?
- Did the DES-exposed children have more risk of developing infantile autism ?
- Diethylstilbestrol activates CatSper and disturbs progesterone actions in human spermatozoa
- Diethylstilbestrol and decreased bone mineralization, osteoporosis
- Diethylstilbestrol clear effect on immunohematology and bone growth
- Diethylstilbestrol Exposure in Utero and Depression in Women
- Breast cancer following diethylstilbestrol exposure in utero : a tragedy ?
- DiEthylStilbestrol, a Gender Bender
- Diethylstilbestrol in Pregnancy
- Different modes of litigation
- Differential gene expression in mice uterine or vaginal tissue following pre or perinatal exposure to DES
- Discordant sexual identity in some genetic males with cloacal exstrophy assigned to female sex at birth
- Disorders of sex differentiation caused by exogenous hormones
- Response of adult mouse uterus to early disruption of estrogen receptor-α signaling is influenced by Krüppel-like factor 9
- Victory for a DES 3rd generation victim : the pharmaceutical company condemned
- Distilbène, effets psychiatriques
- Distilbène et troubles psychiatriques
- Distilbène : un héritage empoisonné
- Rappel de l’historique juridique 1991-2012
- Distilbène®: 20 Years of Legal Battle
- DNA clastogenic activity of diethylstilbestrol
- DNA hypomethylated in primary tumors induced by DES
- DNA methylation and transcriptome aberrations mediated by ERα in mouse seminal vesicles following developmental DES exposure
- Effects of low versus high doses
- Effects of Low-Dose Diethylstilbestrol Exposure on DNA Methylation in Mouse Spermatocytes
- DES neonatal exposure and expressions of DNA methyltransferases
- DES decreases the DNA repair capacity of the Leydig cells
- DES compromises the DNA repair system, accumulating lesions in the genome
- Do endocrine disruptors cause hypospadias?
- Does prenatal exposure to DES have psychiatric consequences?
- Diethylstilbestrol dosage in threatened and habitual abortion and premature labor
- Dosage of Stilbestrol
- DES inhibits transabdominal testicular descent dose-dependently via down-regulating the expression of INSL3
- DES alters vaginal epithelial cell fate through downregulation of RUNX1
- Dr. Dana Beyer talks about DES
- Dr. Scott Kerlin talks about DES
- Five Scary and Shocking Facts about Diethylstilbestrol
- Drug-induced infertility
- DES mediates immune suppression via modulation of microRNA expression
- Early prophylactic cervical cerclage for hypoplastic cervix following exposure to DES in utero
- Ectopic pregnancy after postcoital diethylstilbestrol
- EDCs: an Endocrine Society Scientific Statement
- EDCs effects and mechanisms of actions on behaviour and neuroendocrine systems
- Exposure to endocrine disrupting chemicals and children’s health
- Endocrine Disruptors Affect Developmental Programming of HOX Gene Expression
- Developmental Exposure to Endocrine Disruptors and the Obesity Epidemic
- Endocrine disruptor compounds and their role in the developmental programming of the reproductive axis
- Endocrine disruptor compounds and their role in the developmental programming of the reproductive axis
- EDCs: The Endocrine Society’s Second Scientific Statement
- Effect of neonatal exposure to DES on testicular gene expression
- Effect of diethylstilbestrol on reproductive function
- Effect of neonatal exposure to DES on pelvis and femur
- Effect of prenatal exposure to DES on Müllerian duct development
- Effect of stilbestrol on pregnancy compared to the effect of a placebo
- DES Effects before Birth on Masculine Behavior in Female Monkeys
- Endocrine disrupters and effects on behavioral disorders
- Effects of endocrine disruptors on obesity
- Effects in Men of Intra-Uterine Exposure to DES
- Effects of estrogen treatment on sexual behavior in male-to-female transsexuals
- Effects of Exposure Period and Dose of Diethylstilbestrol on Pregnancy
- Effects of Gestational DES Treatment on Male and Female Gonads during Early Embryonic Development
- Effects of Mullerian anomalies on in vitro fertilization outcome
- Effects of neonatal exposure to DES on protein expression
- Effects of the calcitonins, steroid hormones and thyroid hormones on the response of bone
- Effects of xenoestrogens on the differentiation of behaviorally-relevant neural circuits
- Effects on gender identity of prenatal androgens and genital appearance
- DES effects on the peri-pubertal mammary gland
- In utero DES exposure effects on reproductive capacity in several generations
- Effets transgénérationnels des PE : les leçons du Distilbène
- Uterine EGF levels increased by neonatal DES exposure
- Quels éléments sont vraiment nécessaires pour qu’un dossier DES soit suffisamment étayé ?
- DES as an emergency contraception
- Emergency contraception : 1994 review
- Expanding access to emergency contraception in developing countries
- Emotional distress in morning-after pill patients
- Endocrine Disrupting Chemicals Videos
- Endocrine Disruption : Transgenerational, Epigenetic Effects and Heritability
- Endocrine disruption of oestrogen action and female reproductive tract cancers
- Endocrine Disruptor Induction of Epigenetic Transgenerational Inheritance of Disease
- Endocrine disruptors and behavioural anomalies
- Endocrine Disruptors and Obesity
- Endocrine disruptors and obesity: obesogens
- Endocrine disruptors and psychiatric disorders in children exposed in utero
- Endocrine disruptors as disrupters of brain function
- Endocrine Regulation of HOX Genes
- DES and cardiac problems in ref to endocrine therapy in advanced breast cancer
- DES and cardiac problems in ref to endocrine therapy in metastatic breast cancer
- DES and cardiac problems in ref to endocrine therapy in prostate cancer
- Endometrial pattern in DES-exposed women undergoing IVF
- Enriched environment mitigates the brain-disruptive effects of prenatal DES exposure
- Environmental Agent Signaling
- Environmental endocrine disrupters
- Environmental endocrine disrupters and disorders of sexual differentiation
- Environmental Epigenetics and Its Implication on Disease Risk and Health Outcomes
- Environmental Estrogens and Obesity
- Environmental Estrogens Linked to Reproductive Abnormalities, Cancer
- Environmental Estrogens, Obesity, and Metabolism
- Environmental exposure, DNA methylation, and gene regulation
- Environmental factors, epigenetics, and developmental origin of reproductive disorders
- Environmental factors in genitourinary development
- Environmental signaling
- Prenatal DES exposure and disorders of male sexual differentiation
- Epigenetic alterations induced by in utero diethylstilbestrol exposure
- Epigenetic effects of endocrine-disrupting chemicals on female reproduction : an ovarian perspective
- Epigenetic Mechanism Linking DES to Breast Cancer
- Is the current product safety assessment paradigm protective for epigenetic mechanisms ?
- Epigenetic mechanisms in the actions of endocrine-disrupting chemicals
- Epigenetic transgenerational actions of environmental factors in disease etiology
- Epigenetic Transgenerational Actions of Endocrine Disruptors
- Epigenetics and chemical safety assessment
- Epigenetics and transgenerational effects of DES
- Epigenetics, brain, behavior, and the environment
- Epigenetics and environmental chemicals
- Epigenetics, Evolution, Endocrine Disruption, Health, and Disease
- Epigenetics of schizophrenia : a review
- Epigenetics and transgenerational effects of DES
- Developmental exposure to endocrine disrupting chemicals alters the epigenome
- Epigenomics in Environmental Health
- Ligand-dependent differences in the ability of ERalpha and ERbeta to recruit coactivator proteins
- Uterine expression of the genes Hoxa10, Hoxa11, and Wnt7a after DES treatment
- DES transgenerational oesophageal atresia and tracheo-oesophageal fistula
- Estrogen effects on fetal and neonatal testicular development
- Estrogen fetal exposure and male reproductive health alterations
- Estrogen Imprinting : When Your Epigenetic Memories Come Back to Haunt You
- Estrogen Metabolism in Postmenopausal Women Exposed In Utero to Diethylstilbestrol
- Estrogen receptor-α mediates DES-induced feminization of the seminal vesicle in male
- Estrogen receptor nature influence whether DES responsive genes are activated
- Estrogen receptor stereochemistry: receptor binding and hormonal responses
- Breast Cysts and Lesions following Estrogen Replacement Therapy in the DES-Exposed
- DES exposure during reproductive tract development can reprogram estrogen-responsive gene expression
- DES biological actions involving receptor mediated activities as a mechanism for its toxicity
- Estrogen Treatment of Tall Girls
- Estrogen Treatment for Victims of Rape, 1985
- Estrogen Use in Children and Adolescents: A Survey
- Estrogen use to reduce the growth rate of tall girls
- Estrogenic endocrine disruptive components interfere with calcium handling and differentiation of human trophoblast cells
- Estrogens and development
- Estrogens and postcoital contraception
- Estrogens before birth and development of sex-related reproductive traits
- Ethical and Legal Issues of Including Women in Clinical Studies
- The role of DES in the etiology of cryptorchidism
- Etiology of obesity : Environmental Estrogen DES
- ETRG-1 gene-specific alteration common in DES-induced kidney tumors
- EU Product Liability Conference, 2017
- Evaluation of the ER-alpha expression , mRNA and protein after DES prenatal exposure
- Evidence for decreasing quality of semen during past 50 years
- Evidence for Link Between Mental Disorders and in Utero Exposure to Synthetic Hormones
- Further evidence that prenatal hormone exposure may affect future breast cancer risk
- Evidence that DES genotoxic effects may occur also transplacentally
- Examination of multigenerational transmission of environmental associations
- L’expérience judiciaire individuelle et collective des victimes du Distilbène
- Experience with DES-exposed infertile women in a program of IVF
- Our experience with “morning-after-pill”
- The Synthetic Estrogen Stilbestrol: an Experimental and Clinical Evaluation
- DES experimented without properly designed trials
- Expert witness testimony: a trial judge’s perspective
- L’expertise médicale : du cas par cas pour les victimes du DES
- Exposure to diethylstilbestrol during intrauterine life
- Hypospadias and cryptorchidism associated with diethylstilbestrol
- Exposure to endocrine disrupting chemicals and human health
- Exposure to EDCs during critical phases of development
- Exposure to varying levels of sex steroids early in development can lead to permanent changes in behavior
- EZH2 Expression Transcriptionally Induced by Diethylstilbestrol
- Do epigenetic alterations precede the increased risk of breast neoplasia after in utero exposure to DES ?
- Facebook issue – solved!
- Failure to Identify the Defendant in Tort Law: Towards a Legislative Solution
- DES-mediated regulation of Fas and FasL gene expression
- FDA considers DES safe as ‘morning-after’ pill
- Fear of Disease and Delayed Manifestation of Injuries
- Menstrual history and fecundity of DES-exposed women (in utero)
- Female fertility prognosis and diethylstilbestrol. Personal data and review of the literature
- Female gene expression in the seminal vesicle after prenatal exposure to DES
- DES effects on the female reproductive system
- Feminization in males exposed prenatally to DES
- Feminization of the quail by early DES treatment
- Fertility after in utero exposure to DES
- Fertility and outcome of pregnancy in women exposed in utero to DES
- Fertility and Ovarian Function in High-Dose DES-Treated Tall Women
- Fertility disorders attributable to the use of diethylstilbestrol during intrauterine life
- Fertility in men exposed prenatally to diethylstilbestrol
- DES-treated tall girls fertility, a dose-response relationship
- Fetal and early postnatal environmental exposures and reproductive health effects in the female
- Fetal and perinatal influence of xenoestrogens on testis gene expression
- Fetal exposure to DES results in de-regulation of Wnt7a during uterine morphogenesis
- Fetal germ cell mutation from DES and multi-generational carcinogenesis
- Pregnancy Drugs, Fetal Germline Epigenome, and Risks for Next-Generation Pathology
- Fetal programming of sexual development and reproductive function
- Effect of DES exposure on fetal testis development and function
- Flickr DES Diethylstilbestrol’s Photostream
- Comment la FNATH peut accompagner des victimes du DES sur des questions juridiques
- How DES prescribed during gestation can alter foetal sex differentiation in men
- Follow-up study of male and female offspring of DES-treated mothers
- Follow-up study of male and female offspring of DES-exposed mothers
- Follow-up study of male and female offspring of DES-treated mothers, 1975
- Victimes de médicaments : le fonds d’indemnisation en question
- The FDA is Lying by Omission
- From Res Ipsa Loquitur to Diethylstilbestrol
- The future of hormonal contraception
- DES Regulates Wnt and Fzd Genes in Neonatal Mouse
- DES effects on gubernaculum testis cells mediated by GPER-protein kinase A-ERK-CREB signaling pathway
- Garlic consumption : useful for the prevention of DES-related breast cancer
- Gender assignment : something in the mind, as opposed to the body
- DES “treatment” of a gender-dysphoric transvestite
- Gender Identity and DES Exposure
- Gender-identity, body-experience, sexuality, and the wish for having children in women exposed prenatally to diethylstilbestrol
- Gender Identity, Sexual Orientation, and Sexual Diversity of DES Sons
- Gender-related behavior development in females exposed to DES in utero: an attempted replication
- Gender-related behavior in females following prenatal exposure to DES
- Gender-related behavior in women prenatally exposed to DES
- DES Gene Changes and Proposed Mechanisms of Action
- Gene Expression Alterations in Immune System Pathways in the Thymus after DES Exposure
- Gene expression of DNMT3A, MBD2 and HDAC2 altered in DES-exposed
- Significant alterations in uterine gene expression following neonatal DES exposure
- Differential gene expression in the spleen and thymus following DES exposure
- Organ-specific gene expression patterns altered by in utero DES exposure
- DES impacts on gene expressions in the gubernaculums testis
- DES can developmentally imprint genes by changing the pattern of DNA methylation
- Generic Product Risks: The Case Against Comment k and for Strict Tort Liability
- Discovery of candidate genes and pathways regulating oviduct development in chickens
- Genes p53, p21 and p57 showing the greatest changes in response to DES exposure
- DES exposure causes reprogramming of estrogen-responsive genes expressed in uterine leiomyomas
- Genetic alterations in DES-induced cancer cells
- Genetic factors that control DES-induced thymic atrophy
- Genetic Markers in DES Exposed Daughters
- Developmental DES exposure alters genetic pathways of uterine cytodifferentiation
- Genetic susceptibility to DES sequelae
- Strain differences in the response of the mouse to DES
- Genetic variation in sensitivity to DES and breast cancer risk
- Genetic variation in low-dose effects of neonatal DES exposure in female rats
- Genome damage caused by DES
- Estrogen receptor stereochemistry: ligand binding and hormonal responsiveness
- DES must be considered genotoxic agent
- DES as genotoxic agent leading to breast cancer
- Sex hormones and neoplasia: genotoxic effects in short term assays
- DES genotoxicity causes specific mutations known to induce high risk of breast cancer
- DES exposure alters neonatal germ cell differentiation through Nr0b2
- Germ-line MLH1, MSH2 mutations linked to endometrial cancer
- Germ-line MSH6 mutations linked to endometrial cancer
- Gonadal Hormones and Sexual Differentiation of Human Brain and Behavior
- DES affects the expression of GPER in the gubernaculum testis
- Grandmaternal DES and ADHD in Children
- Grandmaternal DES and ADHD in Children – Costas’ Question
- Grandmaternal DES and ADHD in Children – Ryan’s Question
- Greater Levels of Anger, Anxiety, Concern, Distress, Fear and Worry in DES Daughters
- Effect of prenatal exposure to DES on gubernacular development
- Guidelines for Examination in DES Sons, 1981
- Refocusing on the gynecological and obstetrical consequences of intrauterine exposure to DES
- The Action of Diethylstilbestrol in Gynecologycal Dysfunctions
- Handedness and other laterality indices in women prenatally exposed to DES
- Handedness in women with intrauterine exposure to DES
- Harms to the third generation
- Physician notes hazards of DES use to prevent pregnancy
- Health effects : pregnancy use of diethylstilbestrol
- Wishing a Healthy 2016 to All Readers of Diethylstilbestrol @DES_Journal of a DES Daughter!
- Wishing a Healthy 2017 to All Readers of Diethylstilbestrol @DES_Journal of a DES Daughter!
- Wishing a Healthy 2018 to All Readers of Diethylstilbestrol @DES_Journal of a DES Daughter !
- Wishing You a Healthy Holiday Season
- Hearing loss in DES grandchildren ; a transgenerational effect ?
- Aiming to decrease the estimated final heights of girls via DES hormone treatment
- Histone nuclear proteins are irreversibly modified by reactive metabolites of diethylstilbestrol
- Histopathological and gene expression analysis of mice exposed to diethylstilbestrol
- History of unexplained profoundly low body weight in the DES-exposed women
- HIV, Women and Access to Clinical Trials: Tort Liability and Lessons from DES
- Epigenetic mechanism underlies DES-mediated alterations in HOXA10 expression
- Homeobox gene Msx2 role in female reproductive tract response to DES
- Hormonal contributions to sexually dimorphic behavioral development in humans
- DES Hormone Treatment Tested on Healthy Young Girls to Manipulate Height
- Hormones and behavior : our stolen figures
- Hormones as growth promoters: the precautionary principle or a political risk assessment?
- DES effect measured by host resistance and tumor susceptibility assays
- How long should medical records be kept for the DES-exposed?
- HOX gene expression is altered by DES
- The Role of Hox Genes in Female Reproductive Tract Development, Adult Function, and Fertility
- Hoxa-10 gene expression might be repressed by DES during reproductive tract morphogenesis
- Hox-a10 and Hox-a11 expression potently repressed by perinatal DES exposure
- About Hoxa 10 and Insl3 Genes in the DES exposed
- Mechanisms of reduced fertility in DES Hoxa-10 mutant mice
- hPR gene polymorphism frequency increased in DES-offspring
- Hsp90 and environmental impacts on epigenetic states
- Carcinogenicity of estrogens in human breast epithelial cells
- Environmental chemical exposures and human epigenetics
- Prenatal Exposure to DES linked to Hypermethylation of Homeobox A10
- Hypospadias in DES GrandSons
- Hypospadias in DES Sons
- Hypospadias in DES grandsons : a cohort study
- Hypospadias in rat offspring following exposure to DES
- Hypospadias: risk factor patterns and different phenotypes
- Hypospadias in sons of women exposed to Diethylstilbestrol in utero
- Hypospadias in sons of women exposed to DES in utero
- Hypospadias can be transmitted to the DES-exposed third-generation
- Hypospadias: a transgenerational effect of diethylstilbestrol?
- Hysteroscopic enlargement metroplasty for T-shaped uterus
- Hysteroscopic metroplasty in DES-exposed and hypoplastic uterus
- How Soon Will We Have the “Ideal” Contraceptive ?
- Effects of immunosuppressive or immunotoxic DES exposure
- Immune parameters differences following neonatal DES exposure
- Alterations in immune responsiveness in women exposed to DES in utero
- The immune system of aged individuals is modulated by DES
- Neonatal DES exposure results in immunodeficiency that persists into adulthood
- DES persistent impairment of several immunological parameters
- Genomic analysis of DES induced immunotoxic effects in the thymus
- Impact of environmental endocrine disrupting chemicals on the development of obesity
- Quel impact, sur le plan judiciaire, ont les études publiées en 2014 ?
- Impact of prenatal exposure to DES on psychological outcome
- Prenatal DES exposure and impacted cardiac structure/function in adult males
- Impaired immune function (infectious illness, allergic, autoimmune conditions) in the DES-exposed
- Impaired reproductive performance in Diethylstilbestrol-exposed women
- DES Implications for the Third Generation
- In Re DES Cases (1971 to 1991)
- In utero DES exposure and breast tumours
- In utero DES exposure effect on lumbar and femoral bone, articular cartilage, intervertebral disc
- Association of DES use with increased B‐cell NHL risk
- DES increases breast cancer risk in both exposed mothers and their daughters
- Increased Breast Cancer risk in DES-Exposed Progeny
- Increased tumors but uncompromised fertility in DES female offspring
- Individual constraints on legal action
- Infertility among daughters either exposed or not exposed to diethylstilbestrol
- Infertility among women exposed prenatally to diethylstilbestrol
- Infertility in women exposed to DES in utero
- Informatively empty clusters with application to multigenerational studies
- A molecular basis for estrogen-induced cryptorchidism
- DES drastically reduces Insl3 gene expression
- Prenatal DES-exposure may interfere with testicular Insl3 mRNA expression
- INSL3 and SF-1 mRNA down-regulated expression in a dose-dependent manner following DES exposure
- Interaction of constitutive TGF alpha expression with DES
- DES interception as morning-after pill
- Interferon-gamma levels upregulated by DES
- Interferon-gamma levels are upregulated by DES
- Interleukin-1 (IL-1) related genes persistent expression change following neonatal DES exposure
- International Women’s Day
- Intersexuality and gender identity differentiation
- DES-induced intra-abdominal cryptorchidism
- Intractable primary infertility in DES-exposed women
- Intrauterine factors and breast cancer risk
- Intrauterine factors and risk of breast cancer
- Involvement of insulin-like factor 3 (Insl3) in DES-induced cryptorchidism
- Action of steroid sex hormones on the isolated rabbit heart
- IVF: effect of in-utero DES exposure on human egg quality and fertilization
- Judicially Compelled Disclosure of Researcher’s Data: A Judge’s View
- La jurisprudence relative au DES
- Avancées juridiques du Distilbène : une jurisprudence aléatoire
- DES sold over the counter, in Kenya, to induce abortions
- Lactoferrin Gene Polymorphisms and DES Response
- Lactoferrin gene regulation by estrogen receptor
- Ontogeny of lactoferrin in the developing mouse uterus : a marker of early hormone response
- Language lateralization and handedness in DES-exposed women
- In utero DES exposure and later mammary tumorigenesis
- Lesions of testis and epididymis associated with prenatal diethylstilbestrol exposure
- Lessons learned from perinatal exposure to diethylstilbestrol
- Letter: Ectopic pregnancy after postcoital diethylstilbestrol
- DES inhibit fetal Leydig cell development via estrogen receptor alpha
- Morphological changes during pubertal Leydig cell differentiation following maternal DES exposure
- Molecular events that occur following DES treatment in Leydig cells
- DES Regulates the Expression of LGR8 in Mouse Gubernaculum Testis Cells
- DES affects LGR8 expression in mouse gubernaculum testis
- The DES Cases and the Problem of Proving Causation
- The Effect of Structural Diversity on Ligand Specificity and Resulting Signaling Differences of Estrogen Receptor α
- Lilly, DES and the Law
- Katz v. Eli Lilly & Co.: Limitation of Collateral Estoppel in Products Liability Litigation
- Possible links to the development of obesity
- LXRs modify the neonatal effects of DES on the expression of Leydig and Sertoli cell markers
- Long-term effects of gestational and lactational exposure to DES on testicular gene expression
- Long-term effects of treatment of adolescent tall girls with synthetic hormones
- Long-term follow-up of DES Mothers
- Diethylstilboestrol – A long-term legacy
- Long-term psychiatric and behavioural consequences of prenatal exposure to DES
- The psychological impact of prenatal DES exposure in women
- Low-dose and combined effects of oral exposure to BPA and DES on the male reproductive system
- In utero exposure to both high and low dose diethylstilbestrol disrupts mouse genital tubercle development
- Low-dose perinatal DES exposure affected behaviors
- Findings in female offspring of women exposed in utero to diethylstilbestrol
- DES may suppress lymphocyte mitogenesis through ERalpha in B and T cells
- Genome-wide coexpression of steroid receptors in the mouse brain
- Effects of neonatal administration of DES in male hamsters
- Effects of in utero exposure to DES on male progeny
- Male Pseudohermaphrodism
- Male reproductive health and environmental xenoestrogens
- DES stimulatory effect on the initiation of mammary carcinomas
- DES mammary carcinomas linked to neonatal periods of exposure and doses
- Prenatal diethylstilbestrol exposure and mammographic density
- Mammographic density of adolescent exposure to DES at high-dose
- Mammography screening behaviors of women exposed prenatally to diethylstilbestrol
- Man and Woman, Boy and Girl
- Management of DES-Exposed Patients : Psychological Support
- Management of the diethylstilbestrol-exposed pregnant patient
- DES Manufacturers’ Liability based on a Market Share Theory
- Market Share Liability Adopted to Overcome Defendant Identification Requirement in DES Litigation
- Market Share Liability: an Answer to the DES Causation Problem
- Market Share Liability – Did New York Go Too Far?
- Market Share Liability for DES Diethylstilbestrol Injury
- Market Share Liability in DES Cases
- Market Share Liability Method of Recovery for DES Litigants
- Market Share Liability New York Style: Negligence in the Air
- The Development of Masculine-Typical Function in DES Daughters
- Maternal exposure to DES and sexual dimorphic nucleus volume
- Maternal Obesity Affects Fetal Neurodevelopmental and Metabolic Gene Expression
- Matter of New York County DES Litigation
- Matter of DES Market Share Litigation
- Matter of New York County DES Litigation
- DES Exposure Mechanism leading to Breast Cancer
- Mechanism of action of testosterone on the gonads of male rats treated with stilbestrol
- Mechanisms of angiogenic suppression in uteri exposed to DES neonatally
- Mechanisms of DES carcinogenicity : effects of the TGF alpha transgene
- Mechanisms Underlying Children’s Susceptibility to Environmental Toxicants
- Diethylstilbestrol and Media Coverage of the “Morning After” Pill
- Can the Mediator scandal lead to justice for drug victims ?
- Medical/legal implications of DES long-term sequelae, including 3rd generation
- Medicine and the Law : First DES third-generation injury claim, 1991
- DES Grand Daughters Menstrual and Reproductive Characteristics
- Entre mère et fille, le DES, aspects psychologiques
- Merry Christmas to all Diethylstilbestrol @DES_Journal of a DES Daughter Readers!
- DES metabolic disruption
- Neonatal DES exposure alters the metabolic profile of uterine epithelial cells
- Methylomic changes in individuals with psychosis, prenatally exposed to EDCs
- DNA methyltransferase expression in the human endometrium
- DES strong effects on mice F1 and F2 generations
- DES-induced dysplasia/neoplasia includes a spectrum of microRNA expression alterations
- DES possible role for loss of microsatellite instability
- 1978 DES Case: Mink v. University of Chicago
- DES-Regulated microRNA Expression Profile in Thymocytes
- Mise au point des connaissances en 2002
- DES-induced mitochondrial structural abnormality
- DES mode of action as contraceptive agent
- A molecular basis for DES-induced cryptorchidism
- Molecular feminization of seminal vesicle by prenatal exposure to DES
- From malformations to molecular mechanisms in the male
- Molecular mechanisms of DES-induced carcinogenesis ; risk assessment markers in the DES-exposed
- Morning-After Contraception
- Diethylstilbestrol as a “morning after” contraceptive
- The “morning-after pill”
- The “morning-after pill”, a preliminary report
- DES Mothers and Breast Cancer Risk
- Mouse hypospadias: A critical examination and definition
- In utero exposure to DES alters the mRNA levels of GATA4 and ID2 in the adult testis
- The importance of Msx2 in tissue responsiveness to DES exposure
- Homeodomain Transcription Factor Msx-2 Regulates Uterine Progenitor Cell Response to DES
- DES multi-generational effects on Daphnia magna
- DES multigenerational assay data interpretation
- Intensity of Multigenerational Carcinogenesis from DES
- Association of Exposure to Diethylstilbestrol During Pregnancy With Multigenerational Neurodevelopmental Deficits
- Multiple Causation in Tort Law: Reflections on the DES Cases
- Mutagenic and recombinagenic effects of diethylstilbestrol quinone
- Neonatal acute myeloid leukemia in a DES grandchild infant
- Natural, Environmental and Synthetic Estrogens
- Natural killer cells in in utero diethylstilbesterol-exposed patients
- Diethylstilbestrol negative effect on sperm count
- Neonatal DES exposure adverse effects on somatic cells
- Neonatal DES exposure and tumor formation, demethylation through common cellular process
- Effects of neonatal DES exposure on c-fos and c-jun protooncogene expression
- Neonatal DES exposure caused the differential expression of 900 genes
- Neonatal DES exposure effects on the expression of genes EGF and lactoferrin
- Neonatal DES treatment reduces Hoxa10 and Hoxa11 expression in the uteri
- Neonatal exposure to DES leads to the alteration of gene expression in the testis in the long term
- Neurodevelopmental disorders in children exposed in utero to synthetic progestins
- Normal at Any Cost
- Epigenetic mechanism reprogramming Nsbp1 gene expression by neonatal DES exposure
- DES and Nuclear Receptors
- Perinatal exposure to DES linked to obesity increase in a sex-dependent manner
- Obesogenic endocrine disruptors and obesity
- Observations on the psychological impact of diethylstilbestrol exposure and suggestions on management
- Les obstacles juridiques rencontrés par les victimes du DES
- Obstetric complications and age at onset in schizophrenia
- Obstetric complications, neurodevelopmental deviance, and risk of schizophrenia
- Occurrence of tumours in the descendants of male prenatally exposed to DES
- The ‘oestrogen hypothesis’- where do we stand now ?
- Oestrogen treatment of adolescent tall girls; short term side effects
- Was DES involved in falling sperm counts and disorders of the male reproductive tract ?
- Pharmacologic sex hormones in pregnancy in relation to offspring obesity
- DES Exposure and Offspring Reproductive Health, 1982 Review
- DES still prescribed as oral contraceptive in 1975
- Are oral contraceptives and DES involved in sex-linked cancer ?
- Osseous trabeculae and osteofibrosis as long-term effects of diethylstilbestrol
- Outcome of IVF in DES-exposed daughters: experience in the 90s
- Outcome of pregnancy in patients exposed in utero to diethylstilbestrol
- Ovarian carcinoma in an adolescent with transgenerational exposure to DES
- Ovral touted as morning-after pill
- Ovulation Control with Stilbestrol
- Compounds interfering with ovum implantation and development – The role of estrogens
- Diethylstilbestrol induces oxidative DNA damage
- Possible role of oxygen radicals in cell transformation by diethylstilbestrol and related compounds
- p21 mRNA and protein expressions permanently upregulated following neonatal DES exposure
- DES can induce alterations in the histone modification of the P450scc gene
- DES causal role in p53 expression and in estrogen receptor alterations
- p53 protein expression and gene analysis in clear cell adenocarcinoma of the vagina and cervix
- Differential expression of p63 isoforms in female reproductive organs
- Le Parcours Judiciaire des Victimes du DES, par Maître Verdier
- The Role of Parental and Grandparental Epigenetic Alterations in Familial Cancer Risk
- Le partenariat Réseau DES France / FNATH
- Pas de préjudice d’établissement pour les femmes exposées au DES ayant eu recours à l’adoption
- Pharmacologic and Environmental Endocrine Disruptors in the Pathogenesis of Hypospadias
- Spermatozoal analysis in the DES-exposed males
- Perinatal DES exposure may permanently alter gene expression and methylation
- Perinatal Diethylstilbestrol Exposure and Autoimmune Disease
- Perinatal exposure to environmental estrogens and the development of obesity
- Perinatal risk factors for schizophrenia : how specific are they?
- Permeability of articular cartilage: the effect of certain steroid hormones
- Persistent gene expression in vagina exposed neonatally to DES
- Persistently Altered Epigenetic Marks in the Mouse Uterus After Neonatal DES Exposure
- Perturbed nuclear receptor signaling by DES linked to obesity
- DES et épigénétique : les petites-filles Distilbène, en 2018
- Pharmaceutical Manufacturers Liability for Unforeseen Adverse Drug Reactions
- Pharmaceutical Product Liability
- Pharmacist’s refusal to dispense diethylstilbestrol for contraceptive use
- Pharmacology of estrogens and estrogen-induced effects on nonreproductive organs and systems
- Diethylstilboestrol: I, Pharmacology, Toxicology and Carcinogenicity in Humans, 1992
- Psychiatric disorders among the DES-exposed reportedly twice as common (as for nonexposed persons)
- Physician advisory : health effects of the pregnancy use of diethylstilbestrol
- Pioneering Studies of the “Morning-After” Pill
- Pituitary tumor transforming gene binding factor
- Placental changes due to administration of Diethylstilbestrol DES
- Play behavior affected by early administration of diethylstilbestrol during development
- Political impact outside of the courtrooms
- DES induces polyovular follicles
- Post-coital contraception
- Post-coital DES in large doses
- Post-coital contraception, first-aid use, 1972
- Stilbestrol as post-coital oral contraception
- Post-ovulatory contraception
- DES usage as a post-ovulatory pill
- Postcoital Diethylstilbestrol
- DES use as a postcoital contraceptive agent, 1970
- Postcoital antifertility agents
- DES as postcoital contraception
- Postcoital Contraception, 1970
- Postcoital Contraception With DES
- Postcoital contraception
- Postcoital contraception
- Postcoital contraception : present and future options
- Postcoital contraception underrecognized and underutilized
- Postcoital Contraception with DES, 1974
- Postcoital contraception (without prostaglandins)
- Postcoital contraceptive
- DES use as postcoital contraceptive agent
- Postcoital contraceptives in clinical practice
- DES as postconception fertility control
- Potential interactions between Brca1 or Brca2 gene defects and DES exposure
- Pre- and postnatal influence of DES on differentiation of the sexually dimorphic nucleus of the preoptic area in male and female
- Un précédent manqué : le Distilbène DES
- Preconception Tort Law in an Era of Assisted Reproduction
- Preconception tort liability: recognizing a strict liability cause of action for DES grandchildren
- Preconception Tort Liability – The Duty to Third Generations
- Preeclampsia risk in women exposed in utero to diethylstilbestrol
- Pregnancy after gamete intrafallopian transfer in a DES Daughter with primary infertility
- Pregnancy after transposition and repositioning of the ovaries in a DES-exposed patient
- Pregnancy Outcome in DES Daughters
- Pregnancy outcome in women exposed to diethylstilbestrol in utero
- Pregnancy outcome in women exposed to DES in utero, their mothers, and unexposed siblings
- Pregnancy: DES Effects in DES Mothers and in DES Daughters
- Pregnant DES Daughters and their Offspring
- DES action on fetal heart of pregnant hamsters
- Premature ovarian failures (POF)
- Premenopausal breast cancer after in-utero exposure to stilboestrol
- Prenatal and perinatal risk factors for schizophrenia, affective psychosis, and reactive psychosis of early onset
- Prenatal DES exposure alters Hox gene expression
- Prenatal diethylstilbestrol exposure and autoimmune disease incidence
- Prenatal DES exposure and breast cancer
- Prenatal DES exposure and increased occurrence of autoimmune disease
- Prenatal DES Exposure and Increased Risk of Multiple Sclerosis
- Prenatal diethylstilbestrol exposure and self-reported immune-related diseases
- Prenatal DES Exposure : Behavioral Consequences in Humans
- Prenatal DES exposure in relation to breast size
- Prenatal DES exposure may have long-term immune alterations
- Prenatal DiEthylStilbestrol Exposure in Males and Gender-related Disorders
- Prenatal estrogens and the development of homosexual orientation
- Prenatal exposure to DES alter mammary cancer susceptibility
- Prenatal exposure to DES alter the expression of the lactotransferrin gene in seminal vesicles
- Prenatal Exposure to DES and Methylomic Changes
- Prenatal exposure to DES associated to altered methylation of the gene at the molecular level
- Prenatal Exposure to DES : Effects on Human Development
- Prenatal exposure to DES linked to intersexed development in males
- Prenatal exposure to DES may affect T-cell differentiation and cause long-term effects on the immune functions
- Prenatal exposure to DiEthylStilbestrol and sexual orientation in men and women
- Prenatal exposure to endocrine disrupting chemicals
- Prenatal exposure to endocrine disruptors and neurodevelopment risk
- Prenatal Exposure to Female Hormones
- Prenatal exposure to progesterone suppresses reproduction in male mice
- Prenatal “female hormone” administration and psychosexual development in human males
- Prenatal immunotoxicant exposure and postnatal autoimmune disease
- Prenatal and perinatal risk factors for breast cancer in young women
- Presence of lactoferrin protein in seminal vesicle tissues and secretions of prenatally DES-exposed mice
- Preuve à apporter aux documents source et lien de causalité
- Prevalence of Transsexualism, Transgenderism, Gender Dysphoria, or Intersex among DES-Exposed
- Interception : the use of postovulatory estrogens to prevent implantation
- Primary infertility in DES-exposed women
- Ontogeny of Growth Hormone and Prolactin Gene Expression in Mice
- Ability to produce offspring significantly diminished by DES exposure
- Compensation for Drug Injury
- Product Liability of the 1980s: Repose Is Not the Destiny of Manufacturers
- Products-Liability Class Suits for Injunctive Relief Under Federal Rule 23
- Defining a DES “programming window”
- Prospects for Epigenetic Epidemiology
- Prospects for studying epigenetic mediation of exposure–response relationships
- DES-induced proto-oncogene and suppressor gene expression
- Proto-oncogenes expression in the DES-exposed
- Proving Causation in Toxic Torts Litigation
- Psychological consequences of DES exposure in utero
- Psychological Effects of Diethylstilbestrol Exposure
- Very High Prevalence of Major Depressive Disorder in DES Sons
- Psychopathology in prenatally DES-exposed females
- Psychosexual characteristics of men and women exposed prenatally to DES
- Psychosexual milestones in women prenatally exposed to diethylstilbestrol
- Psychosis and Prenatal Exposure to DES
- Pten gene expression down regulated in DES-promoted cancers
- Neonatal DES exposure inhibitory effect on PTEN-related tumorigenesis
- Real Talk with a DES Son
- Les actions de groupe et le recours collectif
- Effects of prenatal exposure to DES on postnatal reproductive tract function
- Reducing the Adult Height of Tall Girls with DES: Effects on Fertility
- Reductions in fertility in DES sons and daughters
- Relationship between DES exposure in utero and male infertility
- Renal Subcapsular xenografing of human fetal external genital tissue
- Répartition de la dette de réparation des dommages causés par le DES en fonction des parts de marché
- Reproductive and gynecologic surgical experience in diethylstilbestrol-exposed daughters
- Effect of Diethylstilbestrol on Reproductive Function
- Surgical correction of a T-shaped uterus and DES Daughters pregnancy outcome
- Reproductive Outcome of Women exposed to Diethylstilbestrol In Utero
- Reproductive outcomes in men with prenatal exposure to diethylstilbestrol
- Reproductive and hormone-related outcomes in DES third generation women
- Reproductive performance among DES exposed daughters compared with that of their mothers
- Reproductive performance of DES-exposed-female progeny
- Reproductive performance of DES-exposed female progeny
- Reproductive performance of women with müllerian anomalies
- Reproductive problems in the DES-exposed female
- Researchers’ Reactions to Compelled Disclosure of Scientific Information
- Resolving the Problem of Identifying DES Manufacturers
- Demographic, lifestyle, and reproductive risk factors for ectopic pregnancy
- Risk Exposure as Injury: Alleviating the Injustice of Tort Causation Rules
- Risk factors for breast cancer, including occupational exposures
- Risk factors for hypospadias
- DES doses relevant to pregnant women increased later risk of developing mammary tumors
- DES use during pregnancy and fatal breast cancer
- Prenatal diethylstilbestrol exposure and risk of obesity in adult women
- DES induces RNA HOTAIR expression in breast cancer cells
- Role of gene and chromosomal mutations in cell transformation
- Roles of p63 in the DES-induced cervicovaginal adenosis
- Roles of p63 in differentiation of Müllerian duct epithelial cells
- Schizophrenic patients and their first-degree relatives show an excess of mixed-handedness
- DES-induced persistent second-generation developmental abnormalities of the external genitalia
- Secondary sex ratio among women exposed to diethylstilbestrol in utero
- Selective prothymocyte targeting by prenatal diethylstilbesterol exposure
- Self-reported allergy, infection, and autoimmune diseases among men and women exposed in utero to DES
- Serious psychiatric outcome of subjects prenatally exposed to DES
- Settlement effected for damages for victims of diethylstilbestrol
- Sex Steroid Treatment of Constitutionally Tall Stature
- Sexual activity level and sexual functioning in women prenatally exposed to diethylstilbestrol
- Sexual differentiation and environmental endocrine disrupters
- Sexual differentiation of cognitive abilities in prenatally DES-exposed women
- Sexual differentiation of human behavior : effects of prenatal and pubertal organizational hormones
- Sexual Differentiation of the Brain
- Sexual differentiation of the human brain
- Sexual differentiation of the human brain in relation to gender identity and sexual orientation
- Sexual differentiation of the human brain: relation to gender identity, sexual orientation and neuropsychiatric disorders
- Sexual orientation after prenatal exposure to Diethylstilbestrol
- Sindell v. Abbott Labs: a Market Share Approach to DES Causation
- Six cases of women with diethylstilbestrol in utero demonstrating long-term manifestations and current evaluation guideline
- Developmental DES exposure induces persistent endometrial protein SIX1 expression
- Specific morphogenetic events in mouse external genitalia sex differentiation are responsive/dependent upon androgens and/or estrogens
- Standardising compensation
- DES alteration of StAR protein and P450c17 gene
- Statutes of limitations: the special problem of DES suits
- DES exposure linked to alteration in the gene expression of steroidogenic enzymes until adulthood
- Stilbestrol therapy used to “help prevent little girls from growing into big tall girls”
- Structural and functional abnormalities in the sex organs of male offspring of mothers treated with DES
- DES induces structural chromosome aberrations
- Structural and functional abnormalities in the DES sons sex organs
- Structure and function of the fallopian tubes following exposure to diethylstilbestrol during gestation
- DES exposure can disrupt developing organ systems and cause abnormalities that only appear in the subsequent generation
- DES adverse effects are transmitted to subsequent generations
- Suppression of antibody response of male mice exposed to DES
- Suppression of growth in excessively tall girls
- Synthetic Hormone DES given to Healthy Teenage Girls to Manipulate Height
- Synthetic Hormone Use in Beef and The Us Regulatory Dilemma
- DES prenatal exposure affects T-cell differentiation
- DES effects on T-cell differentiation in the thymus
- Tall Girls : The Social Shaping of a Medical Therapy
- Hysteroscopic metroplasty: term delivery rate after T-shaped uterus surgery
- Terminal end buds global gene expression following in utero DES-exposure
- Testicular Dysgenesis Syndrome and the Estrogen Hypothesis: A Quantitative Meta-Analysis
- Testicular dysgenesis syndrome and the estrogen hypothesis: a quantitative meta-analysis
- DES responsibility in the testicular feminization syndrome
- The 1953 Clinical Trial of Diethylstilbestrol During Pregnancy: Could It Have Stopped DES Use?
- DES exposure and the aging woman: mothers and daughters
- The avian egg as a test system for endocrine disrupters
- The Birth of Preconception Torts in Missouri
- The Bitterest Pill
- The Causation Requirement: Guardian of Fairness or Obstacle to Justice
- The Challenge to the Individual Causation Requirement in Mass Products Torts
- The Controversy about DES and Gender Identity
- The DES Manufacturer Identification Problem: A Florida Public Policy Approach
- The DES story: long-term consequences of prenatal exposure
- The DESAD Project Experience
- The Diethylstilbestrol Dilemma: Who Should Pay?
- The Dutch Act on Collective Settlement of Mass Claims (WCAM) Goes Global Again
- The Dutch Class Action (Financial Settlement) Act WCAM
- The effect of DES on gonad development
- The effects of DES before birth on the development of masculine behavior in juvenile female
- The emergence of molecular gynecology : homeobox and Wnt genes in the female reproductive tract
- How the DES tragedy illuminated several crucial concepts embedded in the endocrine disruption hypothesis
- The First DES Class Action Suit: Payton v. Abbott Laboratories
- The history of DES points out prescriptions of a therapeutic without proofs of its efficiency
- The importance of controls in a clinical experiment
- The Indeterminate Defendant in Products Liability Litigation
- The legal mobilization of victims of DES
- Overcoming the Identification Burden in DES Litigation: The Market Share Liability Theory
- The morning after: novel hormonal approaches to postcoital interception, 1983
- The “Morning-After Pill”
- The Nature of the DES Problem and Approaches to Joint Liability
- The Paradox of Statutes of Limitations in Toxic Substances Litigation
- The possible link between DES and being transgender later in life
- The Presence of Gender Dysphoria, Transsexualism, and Disorders of Sex Differentiation in Males Prenatally Exposed to Diethylstilbestrol
- The Relevancy of Drug Efficacy Evidence in Strict Liability Actions
- The Riddle of Gender
- The Role of Estrogen in Sexual Differentiation
- The role of the estrogen receptor in diethylstilbestrol toxicity
- Theories of recovery for DES damage
- Does the Administration of Diethylstilbestrol during Pregnancy have Therapeutic Value ?
- DES side effects in the third generation, known in 2005
- Effects of DES in a Third Generation
- DES and third-generation hypospadias
- Third generation offspring – granddaughters and grandsons
- Time to pregnancy and secondary sex ratio in men exposed prenatally to diethylstilbestrol
- NEW & FREE: DES Awareness Toolbar
- Total health needs of the rape victim
- Toutes les victimes de tous les médicaments doivent être indemnisées
- The trans-generational effects of DES exposure may pose a risk for future generations
- Transgenerational transmission of environmental effects through epigenetic modifications
- DES transgenerational effects not diminishing over three generations
- Transgenerational Epigenetic Inheritance: Focus on Endocrine Disrupting Compounds
- Transgenerational Neurodevelopmental Deficits
- Transgenerational neuroendocrine disruption of reproduction
- Epigenetic transgenerational actions of endocrine disruptors
- Transgenerational Tort Liability for Epigenetic Disease
- Transgenerational transmission of DES-related epigenetic alterations in humans
- DES transgenerational transmission of defects
- Transgenerational transmission of DES effects through epigenetic modifications
- Transplacental effects of diethylstilbestrol in mice
- Transsexualism: a review of etiology, diagnosis and treatment
- Transsexualism : An Unacknowledged Endpoint of Developmental Endocrine Disruption?
- Transvaginal Scan demonstrating a T-shaped Uterus
- Diethylstilbestrol in the Treatment of Rape Victims
- Use of Diethylstilbestrol in the Treatment of Threatened Abortion
- Increased tumor-suppressor-gene penetrance in DES offspring
- Increased susceptibility for tumors transmitted to DES subsequent generations
- Ultrasound Surveillance of the Cervix during Pregnancy in DES Daughters
- DES ultrastructural changes to developing neurons
- Understanding sexual differentiation of the human brain
- Infertility and upper genital tract changes in DES-exposed women
- Induction of urogenital anomalies and some tumors in the progeny of mice receiving diethylstilbestrol during pregnancy
- Urogenital tract abnormalities in DES sons
- Use of DES for postcoital contraception, 1979
- Using DES hormone treatment to reduce the adult height of tall girls
- How DES exposure affects the neonatal uterine epigenome
- Early Life Adverse Environmental Exposures Increase the Risk of Uterine Fibroid Development
- Uterus transplantation in France: for which patients?
- Vascular and morphological changes in uteri exposed to diethylstilbestrol in utero
- DES epigenetically alters ventricular DNA
- Les victimes du DES et la longue, coûteuse et éprouvante voie contentieuse
- Victimes d’effets indésirables graves de médicaments, État des lieux et Recommandations, Version 1.0
- Distilbène : Des Victimes sans Preuves et sans Bourreau ?
- W49392 gene, a biological marker for predicting the effects of neonatal exposure to DES
- DiEthylStilbestrol DES Website New Design
- The weight of expertise
- What causes autism? Exploring the environmental contribution
- Diethylstilbestrol-Induced Mouse Hypospadias: “Window of Susceptibility”
- Wnt-7a deregulation in response to pre-natal exposure to DES
- WNTs in the Neonatal Mouse Uterus: Potential Regulation of Endometrial Gland Development
- Wnt7a mutant uteri display high levels of cell death in response to DES
- Wnt7a disruption : the key event leading to the DES phenotypes and cancers
- Wreaking Reproductive Havoc One Chemical at a Time
- Effect of DES on tissue-specific expression of chicken WNT4
- DES-induced epigenetic repression of microRNA-9-3 in breast epithelial cells
- NEW: YouTube DiEthylStilboestrol’s Channel
- Medical Conditions among Adult Offspring prenatally exposed to DES
- Behavioral and Somatic Disorders in Children Exposed in Utero to Synthetic Hormones
- Transgenerational Inheritance of DES Exposure
- Family History is Underestimated in Children with Isolated Hypospadias
- Breast Cancer in DES Mothers
- DES ability to produce DNA adducts and breast cancer